New Ohio Licensing Requirements

The American Society of Addiction Medicine (ASAM) emailed information regarding a recent Ohio policy update:

Prescribers treating more than thirty individuals for opioid dependence or addiction using a controlled substance now required to obtain a license

On August 4, a regulation from the State of Ohio Board of Pharmacy will go into effect that requires any location where a prescriber is treating more than thirty individuals for opioid dependence or addiction using a controlled substance to obtain a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. While the deadline for licensure is not until August, we believe the Board plans to open the licensing process in the spring to allow enough time for those impacted to obtain licensure.

The Board has created a guidance document to provide information on the regulation for those who will be impacted. It can help answer questions on exemptions to the license requirements and provides further explanation on the other provisions of the regulation, such as physician ownership and criminal records checks. There are links to additional resources on this regulation in the document as well.

Please do not hesitate to contact Brad Bachman, Manager of State Government Relations, at bbachman@asam.org or (301) 547-4107 if you have any specific questions.

Reference:

American Society of Addiction Medicine State Advocacy, e-mail communication, February 28, 2017